{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,17]],"date-time":"2026-07-17T03:40:56Z","timestamp":1784259656894,"version":"3.55.0"},"reference-count":25,"publisher":"Spandidos Publications","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Mol Clin Oncol"],"DOI":"10.3892\/mco.2022.2569","type":"journal-article","created":{"date-parts":[[2022,7,15]],"date-time":"2022-07-15T10:32:50Z","timestamp":1657881170000},"source":"Crossref","is-referenced-by-count":16,"title":["Application of PD\u2011L1 blockade in refractory histiocytic sarcoma: A case report"],"prefix":"10.3892","volume":"17","author":[{"given":"Osamu","family":"Imataki","sequence":"first","affiliation":[{"name":"Division of Hematology, Department of Internal Medicine, Faculty of Medicine, Kagawa University, Miki, Kagawa 761\u20110793, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Makiko","family":"Uemura","sequence":"additional","affiliation":[{"name":"Division of Hematology, Department of Internal Medicine, Faculty of Medicine, Kagawa University, Miki, Kagawa 761\u20110793, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haruyuki","family":"Fujita","sequence":"additional","affiliation":[{"name":"Division of Hematology, Department of Internal Medicine, Faculty of Medicine, Kagawa University, Miki, Kagawa 761\u20110793, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Norimitsu","family":"Kadowaki","sequence":"additional","affiliation":[{"name":"Division of Hematology, Department of Internal Medicine, Faculty of Medicine, Kagawa University, Miki, Kagawa 761\u20110793, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"2249","published-online":{"date-parts":[[2022,7,15]]},"reference":[{"key":"key20220826091646_b1-MCO-17-3-02569","author":"Swerdlow"},{"key":"key20220826091646_b2-MCO-17-3-02569","doi-asserted-by":"publisher","first-page":"2375","DOI":"10.1182\/blood-2016-01-643569","article-title":"The 2016 revision of the world health organization classification of lymphoid neoplasms","volume":"127","author":"Swerdlow","year":"2016","journal-title":"Blood"},{"key":"key20220826091646_b3-MCO-17-3-02569","doi-asserted-by":"publisher","first-page":"2672","DOI":"10.1182\/blood-2016-01-690636","article-title":"Revised classification of histiocytoses and neoplasms of the macrophage-dendritic cell lineages","volume":"127","author":"Emile","year":"2016","journal-title":"Blood"},{"key":"key20220826091646_b4-MCO-17-3-02569","doi-asserted-by":"publisher","first-page":"650","DOI":"10.5858\/arpa.2018-0349-RS","article-title":"Histiocytic sarcoma","volume":"144","author":"Hung","year":"2020","journal-title":"Arch Pathol Lab Med"},{"key":"key20220826091646_b5-MCO-17-3-02569","doi-asserted-by":"publisher","first-page":"19819","DOI":"10.18632\/oncotarget.4378","article-title":"Disseminated histiocytoses biomarkers beyond BRAFV600E: Frequent expression of PD-L1","volume":"6","author":"Gatalica","year":"2015","journal-title":"Oncotarget"},{"key":"key20220826091646_b6-MCO-17-3-02569","doi-asserted-by":"publisher","first-page":"1365","DOI":"10.1038\/70932","article-title":"B7-H1, a third member of the B7 family, co-stimulates T-cell proliferation and interleukin-10 secretion","volume":"5","author":"Dong","year":"1999","journal-title":"Nat Med"},{"key":"key20220826091646_b7-MCO-17-3-02569","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1016\/j.coi.2007.04.012","article-title":"PD-1 and its ligands in T-cell immunity","volume":"19","author":"Keir","year":"2007","journal-title":"Curr Opin Immunol"},{"issue":"167","key":"key20220826091646_b8-MCO-17-3-02569","doi-asserted-by":"publisher","DOI":"10.1186\/s13014-018-1115-x","article-title":"Primary histiocytic sarcoma of the central nervous system: A case report with platelet derived growth factor receptor mutation and PD-L1\/PD-L2 expression and literature review","volume":"13","author":"May","year":"2018","journal-title":"Radiat Oncol"},{"key":"key20220826091646_b9-MCO-17-3-02569","doi-asserted-by":"publisher","first-page":"2413","DOI":"10.1016\/j.ejca.2015.06.109","article-title":"Impact of surgery, radiation and systemic therapy on the outcomes of patients with dendritic cell and histiocytic sarcomas","volume":"51","author":"Gounder","year":"2015","journal-title":"Eur J Cancer"},{"key":"key20220826091646_b10-MCO-17-3-02569","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1007\/s12185-017-2202-8","article-title":"Successful treatment of histiocytic sarcoma with cladribine and high-dose cytosine arabinoside in a child","volume":"106","author":"Iwabuchi","year":"2017","journal-title":"Int J Hematol"},{"key":"key20220826091646_b11-MCO-17-3-02569","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1182\/blood-2017-10-812495","article-title":"Histiocytic sarcoma: A population-based analysis of incidence, demographic disparities, and long-term outcomes","volume":"131","author":"Kommalapati","year":"2018","journal-title":"Blood"},{"key":"key20220826091646_b12-MCO-17-3-02569","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1111\/ejh.12755","article-title":"Histiocytic sarcoma as a secondary malignancy: Pathobiology, diagnosis, and treatment","volume":"97","author":"Ansari","year":"2016","journal-title":"Eur J Haematol"},{"key":"key20220826091646_b13-MCO-17-3-02569","doi-asserted-by":"publisher","first-page":"1322","DOI":"10.5858\/arpa.2018-0220-RA","article-title":"Histiocytic Sarcoma: Review, discussion of transformation from B-cell lymphoma, and differential diagnosis","volume":"142","author":"Skala","year":"2018","journal-title":"Arch Pathol Lab Med"},{"issue":"e27491","key":"key20220826091646_b14-MCO-17-3-02569","doi-asserted-by":"publisher","DOI":"10.1002\/pbc.27491","article-title":"Favorable response to nivolumab in a young adult patient with metastatic histiocytic sarcoma","volume":"66","author":"Bose","year":"2019","journal-title":"Pediatr Blood Cancer"},{"key":"key20220826091646_b15-MCO-17-3-02569","doi-asserted-by":"publisher","first-page":"2117","DOI":"10.1007\/s00277-018-3436-0","article-title":"Histiocytic cell neoplasms involving the bone marrow: Summary of the workshop cases submitted to the 18th meeting of the European association for haematopathology (EAHP) organized by the European bone marrow working group, basel 2016","volume":"97","author":"Tzankov","year":"2018","journal-title":"Ann Hematol"},{"key":"key20220826091646_b16-MCO-17-3-02569","doi-asserted-by":"publisher","first-page":"4060","DOI":"10.18632\/oncotarget.2061","article-title":"Potential clinical implications of BRAF mutations in histiocytic proliferations","volume":"5","author":"Bubolz","year":"2014","journal-title":"Oncotarget"},{"key":"key20220826091646_b17-MCO-17-3-02569","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3960\/jslrt.53.1","article-title":"Histiocytic sarcoma: An updated literature review based on the 2008 WHO classification","volume":"53","author":"Takahashi","year":"2013","journal-title":"J Clin Exp Hematop"},{"key":"key20220826091646_b18-MCO-17-3-02569","doi-asserted-by":"publisher","first-page":"553","DOI":"10.1080\/10428194.2018.1492128","article-title":"Predictors of survival, treatment patterns, and outcomes in histiocytic sarcoma","volume":"60","author":"Kommalapati","year":"2019","journal-title":"Leuk Lymphoma"},{"key":"key20220826091646_b19-MCO-17-3-02569","doi-asserted-by":"publisher","first-page":"98723","DOI":"10.18632\/oncotarget.21920","article-title":"Prognostic factors for histiocytic and dendritic cell neoplasms","volume":"8","author":"Shimono","year":"2017","journal-title":"Oncotarget"},{"issue":"755893","key":"key20220826091646_b20-MCO-17-3-02569","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2021.755893","article-title":"Case Report: Long-term response to radiotherapy combined with targeted therapy in histiocytic sarcoma harboring mutations in MAPK and PI3K\/AKT pathways","volume":"11","author":"Liu","year":"2021","journal-title":"Front Oncol"},{"key":"key20220826091646_b21-MCO-17-3-02569","doi-asserted-by":"publisher","first-page":"1","DOI":"10.6004\/jnccn.2022.7001","article-title":"Near complete response to trametinib treatment in histiocytic sarcoma harboring a somatic KRAS mutation","volume":"24","author":"Hu","year":"2022","journal-title":"J Natl Compr Canc Netw"},{"key":"key20220826091646_b22-MCO-17-3-02569","doi-asserted-by":"publisher","first-page":"444","DOI":"10.1111\/ejh.13303","article-title":"Targeted therapy of BRAF V600E-mutant histiocytic sarcoma: A case report and review of the literature","volume":"103","author":"Branco","year":"2019","journal-title":"Eur J Haematol"},{"issue":"728260","key":"key20220826091646_b23-MCO-17-3-02569","doi-asserted-by":"publisher","DOI":"10.1155\/2015\/728260","article-title":"Successful treatment of multifocal histiocytic sarcoma occurring after renal transplantation with cladribine, high-dose cytarabine, G-CSF, and mitoxantrone (CLAG-M) followed by allogeneic hematopoietic stem cell transplantation","volume":"2015","author":"Tomlin","year":"2015","journal-title":"Case Rep Hematol"},{"key":"key20220826091646_b24-MCO-17-3-02569","doi-asserted-by":"publisher","first-page":"e251","DOI":"10.1200\/JCO.2010.32.6603","article-title":"Autologous hematopoietic stem-cell transplantation in combination with thalidomide as treatment for histiocytic sarcoma: A case report and review of the literature","volume":"29","author":"Gergis","year":"2011","journal-title":"J Clin Oncol"},{"key":"key20220826091646_b25-MCO-17-3-02569","first-page":"1789","article-title":"Successful treatment of canine malignant histiocytosis with the human major histocompatibility complex nonrestricted cytotoxic T-cell line TALL-104","volume":"3","author":"Visonneau","year":"1997","journal-title":"Clin Cancer Res"}],"container-title":["Molecular and Clinical Oncology"],"original-title":[],"deposited":{"date-parts":[[2022,8,26]],"date-time":"2022-08-26T06:17:08Z","timestamp":1661494628000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.spandidos-publications.com\/10.3892\/mco.2022.2569"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,7,15]]},"references-count":25,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2022,7,15]]}},"URL":"https:\/\/doi.org\/10.3892\/mco.2022.2569","relation":{},"ISSN":["2049-9450","2049-9469"],"issn-type":[{"value":"2049-9450","type":"print"},{"value":"2049-9469","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,7,15]]},"article-number":"136"}}